clinical trial · NCT06797674
A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)
Merck Sharp & Dohme LLC·phase1·completed·n = 34
HealthyMK-7602Efavirenz
brief summary
The goal of the study is to learn what happens to levels of MK-7602 in a healthy person's body over time. Researchers will compare what happens to MK-7602 in the body when it is given with or without another medicine called efavirenz, and when it is given with or without a meal.
started
Feb 10, 2025
primary completion
Aug 12, 2025
completion
Aug 12, 2025
last updated
Aug 22, 2025
official title
A Clinical Study to Evaluate the Effect of Multiple Doses of Efavirenz on Single-Dose Pharmacokinetics of MK-7602 in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol